RU2568884C2 - Компенсация невязки для биодатчика - Google Patents
Компенсация невязки для биодатчика Download PDFInfo
- Publication number
- RU2568884C2 RU2568884C2 RU2012144625/15A RU2012144625A RU2568884C2 RU 2568884 C2 RU2568884 C2 RU 2568884C2 RU 2012144625/15 A RU2012144625/15 A RU 2012144625/15A RU 2012144625 A RU2012144625 A RU 2012144625A RU 2568884 C2 RU2568884 C2 RU 2568884C2
- Authority
- RU
- Russia
- Prior art keywords
- function
- sample
- output signal
- error
- residual
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 88
- 239000000126 substance Substances 0.000 claims abstract description 15
- 238000012360 testing method Methods 0.000 claims description 256
- 239000012491 analyte Substances 0.000 claims description 131
- 238000005534 hematocrit Methods 0.000 claims description 68
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 48
- 239000008103 glucose Substances 0.000 claims description 48
- 210000004369 blood Anatomy 0.000 claims description 44
- 239000008280 blood Substances 0.000 claims description 44
- 238000003860 storage Methods 0.000 claims description 25
- 230000007717 exclusion Effects 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 230000035945 sensitivity Effects 0.000 claims description 9
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 2
- 238000005259 measurement Methods 0.000 abstract description 53
- 238000004458 analytical method Methods 0.000 abstract description 47
- 230000000694 effects Effects 0.000 abstract description 13
- 239000007788 liquid Substances 0.000 abstract description 8
- 239000000523 sample Substances 0.000 description 146
- 238000004519 manufacturing process Methods 0.000 description 29
- 230000003287 optical effect Effects 0.000 description 29
- 230000006872 improvement Effects 0.000 description 20
- 239000004020 conductor Substances 0.000 description 17
- 230000002829 reductive effect Effects 0.000 description 16
- 230000004044 response Effects 0.000 description 16
- 239000013060 biological fluid Substances 0.000 description 14
- 230000000875 corresponding effect Effects 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000006479 redox reaction Methods 0.000 description 9
- 230000007613 environmental effect Effects 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000004082 amperometric method Methods 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000009897 systematic effect Effects 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 238000004832 voltammetry Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000004313 potentiometry Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005429 filling process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- -1 or a reaction Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 102220045637 rs587782266 Human genes 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31617410P | 2010-03-22 | 2010-03-22 | |
| US61/316,174 | 2010-03-22 | ||
| PCT/US2011/029318 WO2011119533A1 (en) | 2010-03-22 | 2011-03-22 | Residual compensation for a biosensor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012144625A RU2012144625A (ru) | 2014-04-27 |
| RU2568884C2 true RU2568884C2 (ru) | 2015-11-20 |
Family
ID=44065188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012144625/15A RU2568884C2 (ru) | 2010-03-22 | 2011-03-22 | Компенсация невязки для биодатчика |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10591436B2 (enExample) |
| EP (1) | EP2550530A1 (enExample) |
| JP (1) | JP6096655B2 (enExample) |
| KR (1) | KR101929057B1 (enExample) |
| CN (1) | CN103003692B (enExample) |
| BR (1) | BR112012023984A2 (enExample) |
| CA (1) | CA2793878C (enExample) |
| MX (2) | MX2012010860A (enExample) |
| RU (1) | RU2568884C2 (enExample) |
| WO (1) | WO2011119533A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2550530A1 (en) | 2010-03-22 | 2013-01-30 | Bayer HealthCare LLC | Residual compensation for a biosensor |
| EP2577303B1 (en) * | 2010-06-07 | 2022-08-03 | Ascensia Diabetes Care Holdings AG | Underfill management system for a biosensor |
| HK1221771A1 (zh) * | 2013-03-14 | 2017-06-09 | 安晟信医疗科技控股公司 | 分析物浓度测定的标准化校准 |
| CN105283765B (zh) * | 2013-03-14 | 2018-01-16 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
| US9933441B2 (en) | 2013-03-14 | 2018-04-03 | Ascensia Diabetes Care Holdings Ag | Progressive approximation of sample analyte concentration |
| EP2781919A1 (en) * | 2013-03-19 | 2014-09-24 | Roche Diagniostics GmbH | Method / device for generating a corrected value of an analyte concentration in a sample of a body fluid |
| EP3295159B1 (en) | 2015-05-15 | 2021-12-01 | Ascensia Diabetes Care Holdings AG | Improved biosensor system analyte measurement |
| CN109690304A (zh) | 2016-07-12 | 2019-04-26 | 安晟信医疗科技控股公司 | 通过使用来自两个电极的交替输出信号进行电化学分析的方法 |
| ES2856174T3 (es) * | 2016-09-07 | 2021-09-27 | Hoffmann La Roche | Procedimientos para someter a prueba sensores electroquímicos basados en enzimas |
| EP3548881A1 (en) | 2016-12-05 | 2019-10-09 | Ascensia Diabetes Care Holdings AG | Risk factor monitoring |
| CN109682968B (zh) * | 2018-11-08 | 2022-03-11 | 上海艾瑞德生物科技有限公司 | 一种荧光免疫试条定量检测测试信号温度矫正方法 |
| US12478297B2 (en) | 2019-11-27 | 2025-11-25 | Senseonics, Incorporated | Methods and systems for reducing difference between calculated and measured analyte levels |
| US11864892B2 (en) | 2019-11-27 | 2024-01-09 | Senseonics, Incorporated | Methods and systems for reducing difference between calculated and measured analyte levels |
| CN111812175B (zh) * | 2020-06-30 | 2022-06-14 | 江苏鱼跃医疗设备股份有限公司 | 一种降低红细胞比容干扰的血液检测方法及生物传感器 |
| CA3185895A1 (en) * | 2020-08-04 | 2022-02-10 | Huan-Ping Wu | Non-steady-state determination of analyte concentration for continuous glucose monitoring by potential modulation |
| EP4082436A1 (en) * | 2021-04-29 | 2022-11-02 | Roche Diabetes Care GmbH | Method for determining a reliability of an analyte sensor |
| CN113607801B (zh) * | 2021-08-09 | 2023-09-29 | 湖南国天电子科技有限公司 | 一种多级可控激发电压控制模块延长传感器寿命的方法 |
| CN116560179B (zh) * | 2023-04-13 | 2026-05-15 | 上海华力集成电路制造有限公司 | Bse补偿装置及其使用方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2050545C1 (ru) * | 1989-04-25 | 1995-12-20 | Миграта Юк Лтд. | Способ определения содержания глюкозы в цельной крови, фотометр для его реализации |
| RU2135993C1 (ru) * | 1994-07-12 | 1999-08-27 | Научно-исследовательский институт радиоэлектроники и лазерной техники МГТУ им.Н.Э.Баумана | Устройство для определения концентрации водно-спиртового раствора |
| RU2194987C2 (ru) * | 2000-05-26 | 2002-12-20 | Научно-исследовательский институт кардиологии Томского научного центра СО РАМН | Способ количественного определения катехоламинов в моче |
| RU2241985C1 (ru) * | 2003-03-27 | 2004-12-10 | Томский политехнический университет | Способ количественного определения азитромицина дигидрата методом инверсионной вольтамперометрии |
Family Cites Families (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431004A (en) | 1981-10-27 | 1984-02-14 | Bessman Samuel P | Implantable glucose sensor |
| US4750496A (en) | 1987-01-28 | 1988-06-14 | Xienta, Inc. | Method and apparatus for measuring blood glucose concentration |
| US5508171A (en) | 1989-12-15 | 1996-04-16 | Boehringer Mannheim Corporation | Assay method with enzyme electrode system |
| US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| FR2701117B1 (fr) | 1993-02-04 | 1995-03-10 | Asulab Sa | Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose. |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
| US6153069A (en) | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| US5582697A (en) | 1995-03-17 | 1996-12-10 | Matsushita Electric Industrial Co., Ltd. | Biosensor, and a method and a device for quantifying a substrate in a sample liquid using the same |
| US5620579A (en) | 1995-05-05 | 1997-04-15 | Bayer Corporation | Apparatus for reduction of bias in amperometric sensors |
| US5723284A (en) | 1996-04-01 | 1998-03-03 | Bayer Corporation | Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood |
| AU6157898A (en) | 1997-02-06 | 1998-08-26 | E. Heller & Company | Small volume (in vitro) analyte sensor |
| US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US5798031A (en) | 1997-05-12 | 1998-08-25 | Bayer Corporation | Electrochemical biosensor |
| US6391645B1 (en) | 1997-05-12 | 2002-05-21 | Bayer Corporation | Method and apparatus for correcting ambient temperature effect in biosensors |
| EP0990151A2 (en) | 1997-06-16 | 2000-04-05 | ELAN CORPORATION, Plc | Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods |
| HU222809B1 (hu) | 1997-10-03 | 2003-10-28 | 77 Elektronika Műszeripari Kft. | Eljárás és készülék kémiai összetevőnek anyagmintából, különösen vér glükóztartalmának vérmintából történő meghatározásához |
| JP3260739B2 (ja) | 1997-12-22 | 2002-02-25 | ロシュ ダイアグノスティックス コーポレーション | 生物学的流体の医学的に有意な成分の濃度を測定する装置および方法 |
| US6233471B1 (en) | 1998-05-13 | 2001-05-15 | Cygnus, Inc. | Signal processing for measurement of physiological analysis |
| AU3849799A (en) | 1998-05-20 | 1999-12-06 | Arkray, Inc. | Method and apparatus for electrochemical measurement using statistical technique |
| US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| CA2305922C (en) | 1999-08-02 | 2005-09-20 | Bayer Corporation | Improved electrochemical sensor design |
| WO2001021827A1 (en) | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
| US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
| JP4050434B2 (ja) | 1999-11-29 | 2008-02-20 | 松下電器産業株式会社 | サンプルの弁別方法 |
| WO2002057768A1 (fr) | 2001-01-17 | 2002-07-25 | Arkray, Inc. | Procede d'analyse quantitative et dispositif d'analyse quantitative utilisant un capteur |
| US6541266B2 (en) | 2001-02-28 | 2003-04-01 | Home Diagnostics, Inc. | Method for determining concentration of an analyte in a test strip |
| US6562625B2 (en) | 2001-02-28 | 2003-05-13 | Home Diagnostics, Inc. | Distinguishing test types through spectral analysis |
| AU784254B2 (en) | 2001-05-21 | 2006-03-02 | Bayer Corporation | Improved electrochemical sensor |
| US6797150B2 (en) | 2001-10-10 | 2004-09-28 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| JP4246633B2 (ja) | 2001-10-12 | 2009-04-02 | アークレイ株式会社 | 濃度測定方法および濃度測定装置 |
| US6872298B2 (en) * | 2001-11-20 | 2005-03-29 | Lifescan, Inc. | Determination of sample volume adequacy in biosensor devices |
| CA2419213C (en) | 2002-03-07 | 2011-06-21 | Bayer Healthcare Llc | Improved electrical sensor |
| US6964871B2 (en) | 2002-04-25 | 2005-11-15 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| AU2003234944A1 (en) | 2002-08-27 | 2004-03-18 | Bayer Healthcare, Llc | Methods of Determining Glucose Concentration in Whole Blood Samples |
| ATE363069T1 (de) * | 2002-11-21 | 2007-06-15 | Lifescan Inc | Bestimmung der genauigkeit eines probevolumens in biosensoren |
| US7132041B2 (en) | 2003-02-11 | 2006-11-07 | Bayer Healthcare Llc | Methods of determining the concentration of an analyte in a fluid test sample |
| EP1467206A1 (en) * | 2003-04-08 | 2004-10-13 | Roche Diagnostics GmbH | Biosensor system |
| JP4222896B2 (ja) | 2003-07-25 | 2009-02-12 | テルモ株式会社 | 成分測定装置 |
| US7488601B2 (en) | 2003-06-20 | 2009-02-10 | Roche Diagnostic Operations, Inc. | System and method for determining an abused sensor during analyte measurement |
| US7452457B2 (en) | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
| ES2709991T3 (es) | 2003-08-21 | 2019-04-22 | Agamatrix Inc | Método y aparato para el análisis de propiedades electroquímicas |
| JP4449431B2 (ja) | 2003-11-19 | 2010-04-14 | パナソニック株式会社 | 基質濃度の測定方法 |
| RU2371707C2 (ru) | 2004-02-06 | 2009-10-27 | БАЙЕР ХЕЛТКЭР ЭлЭлСи | Электрохимический биодатчик |
| CN100337589C (zh) * | 2004-02-27 | 2007-09-19 | 株式会社日立制作所 | 血糖值测定装置 |
| KR101196278B1 (ko) | 2004-03-08 | 2012-11-06 | 쉘 인터내셔날 리써취 마트샤피지 비.브이. | 반응기용 가스 분배기 |
| JP4689601B2 (ja) | 2004-04-19 | 2011-05-25 | パナソニック株式会社 | 血液成分の測定方法、それに用いるバイオセンサおよび測定装置 |
| RU2006144458A (ru) | 2004-05-14 | 2008-06-20 | БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) | Способы осуществления корректировки по гематокриту в анализах глюкозы и устройства для этого |
| AU2005295106B2 (en) | 2004-10-12 | 2012-03-15 | Bayer Healthcare Llc | Concentration determination in a diffusion barrier layer |
| GB0501826D0 (en) | 2005-01-28 | 2005-03-09 | Melys Diagnostics Ltd | Apparatus for measurement of analyte concentration |
| PL2267150T3 (pl) | 2005-04-08 | 2016-03-31 | Bayer Healthcare Llc | Utlenialne związki chemiczne jako wzorzec wewnętrzny w roztworach kontrolnych do bioczujników |
| US7517439B2 (en) | 2005-04-15 | 2009-04-14 | Agamatrix, Inc. | Error detection in analyte measurements based on measurement of system resistance |
| CN101297196B (zh) * | 2005-07-20 | 2013-10-30 | 拜尔健康护理有限责任公司 | 门控电流分析法 |
| EP3483599A1 (en) | 2005-07-20 | 2019-05-15 | Ascensia Diabetes Care Holdings AG | Methods for measuring the concentration of an analyte in solution and for calibrating the measurement as well as handheld devices therefor |
| CN103048442B (zh) | 2005-09-30 | 2015-04-08 | 拜尔健康护理有限责任公司 | 门控伏特安培法 |
| RU2455925C2 (ru) * | 2006-02-27 | 2012-07-20 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Определение исследуемого вещества с поправкой на температуру для систем биодатчиков |
| US7966859B2 (en) | 2006-05-03 | 2011-06-28 | Bayer Healthcare Llc | Underfill detection system for a biosensor |
| JP5121822B2 (ja) | 2006-05-08 | 2013-01-16 | バイエル・ヘルスケア・エルエルシー | バイオセンサ用異常出力検出システム |
| US8305564B2 (en) | 2006-05-16 | 2012-11-06 | Arkray, Inc. | Method for automatically discriminating control solution |
| US7699973B2 (en) | 2006-06-30 | 2010-04-20 | Abbott Diabetes Care Inc. | Rapid analyte measurement assay |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US8658094B2 (en) | 2007-01-29 | 2014-02-25 | Nalco Company | High temperature and pressure oxidation-reduction potential measuring and monitoring device for hot water systems |
| US20080248581A1 (en) | 2007-04-06 | 2008-10-09 | Bayer Healthcare Llc | Method for performing correction of blood glucose assay bias using blood hemoglobin concentration |
| TWI453401B (zh) | 2007-07-26 | 2014-09-21 | Nipro Diagnostics Inc | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| US8101062B2 (en) | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| RU2706691C2 (ru) * | 2007-12-10 | 2019-11-20 | Асцензия Диабетс Кэар Холдингс АГ | Способ определения концентрации аналита |
| EP2364138A2 (en) | 2008-12-08 | 2011-09-14 | Teva Pharmaceutical Industries Ltd. | Palonosetron formulation |
| RU2509304C2 (ru) | 2008-12-08 | 2014-03-10 | БАЙЕР ХЕЛТКЭА ЭлЭлСи | Биосенсорная система с корректировкой сигнала |
| WO2011059670A1 (en) | 2009-11-10 | 2011-05-19 | Bayer Healthcare Llc | Underfill recognition system for a biosensor |
| EP2550530A1 (en) | 2010-03-22 | 2013-01-30 | Bayer HealthCare LLC | Residual compensation for a biosensor |
| KR102068949B1 (ko) | 2010-06-07 | 2020-01-21 | 바이엘 헬쓰케어 엘엘씨 | 2차 출력 신호를 포함하는 기울기-기반 보상 |
| EP3586831A1 (en) * | 2011-09-21 | 2020-01-01 | Ascensia Diabetes Care Holdings AG | Analysis compensation including segmented signals |
| US9933441B2 (en) * | 2013-03-14 | 2018-04-03 | Ascensia Diabetes Care Holdings Ag | Progressive approximation of sample analyte concentration |
| CN105283765B (zh) * | 2013-03-14 | 2018-01-16 | 安晟信医疗科技控股公司 | 分析物浓度测定的系统误差补偿 |
-
2011
- 2011-03-22 EP EP11712389A patent/EP2550530A1/en not_active Ceased
- 2011-03-22 CA CA2793878A patent/CA2793878C/en not_active Expired - Fee Related
- 2011-03-22 RU RU2012144625/15A patent/RU2568884C2/ru active
- 2011-03-22 JP JP2013501366A patent/JP6096655B2/ja active Active
- 2011-03-22 MX MX2012010860A patent/MX2012010860A/es active IP Right Grant
- 2011-03-22 US US13/053,722 patent/US10591436B2/en active Active
- 2011-03-22 KR KR1020127027529A patent/KR101929057B1/ko active Active
- 2011-03-22 CN CN201180025412.5A patent/CN103003692B/zh active Active
- 2011-03-22 WO PCT/US2011/029318 patent/WO2011119533A1/en not_active Ceased
- 2011-03-22 MX MX2015008896A patent/MX368104B/es unknown
- 2011-03-22 BR BR112012023984A patent/BR112012023984A2/pt not_active IP Right Cessation
-
2020
- 2020-02-04 US US16/781,767 patent/US11988626B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2050545C1 (ru) * | 1989-04-25 | 1995-12-20 | Миграта Юк Лтд. | Способ определения содержания глюкозы в цельной крови, фотометр для его реализации |
| RU2135993C1 (ru) * | 1994-07-12 | 1999-08-27 | Научно-исследовательский институт радиоэлектроники и лазерной техники МГТУ им.Н.Э.Баумана | Устройство для определения концентрации водно-спиртового раствора |
| RU2194987C2 (ru) * | 2000-05-26 | 2002-12-20 | Научно-исследовательский институт кардиологии Томского научного центра СО РАМН | Способ количественного определения катехоламинов в моче |
| RU2241985C1 (ru) * | 2003-03-27 | 2004-12-10 | Томский политехнический университет | Способ количественного определения азитромицина дигидрата методом инверсионной вольтамперометрии |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2550530A1 (en) | 2013-01-30 |
| CA2793878A1 (en) | 2011-09-29 |
| US11988626B2 (en) | 2024-05-21 |
| RU2012144625A (ru) | 2014-04-27 |
| US10591436B2 (en) | 2020-03-17 |
| US20110231105A1 (en) | 2011-09-22 |
| CN103003692B (zh) | 2015-01-14 |
| MX368104B (es) | 2019-09-19 |
| CA2793878C (en) | 2018-09-11 |
| KR101929057B1 (ko) | 2018-12-13 |
| KR20130016311A (ko) | 2013-02-14 |
| JP2013522647A (ja) | 2013-06-13 |
| MX2012010860A (es) | 2013-03-05 |
| US20200173952A1 (en) | 2020-06-04 |
| BR112012023984A2 (pt) | 2016-08-02 |
| WO2011119533A1 (en) | 2011-09-29 |
| HK1177260A1 (en) | 2013-08-16 |
| CN103003692A (zh) | 2013-03-27 |
| JP6096655B2 (ja) | 2017-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11988626B2 (en) | Residual compensation including underfill error | |
| US10921278B2 (en) | Slope-based compensation including secondary output signals | |
| US10175194B2 (en) | Underfill management system for a biosensor | |
| JP5738770B2 (ja) | 信号調整を持つバイオセンサシステム | |
| RU2455925C2 (ru) | Определение исследуемого вещества с поправкой на температуру для систем биодатчиков | |
| EP2758039B1 (en) | Biosensor with error compensation | |
| JP2012511160A5 (enExample) | ||
| JP6494813B2 (ja) | 分析物濃度決定のシステム誤差補償 | |
| EP3276355B1 (en) | Normalized calibration of analyte concentration determinations | |
| JP2016517517A5 (enExample) | ||
| HK1177260B (en) | Residual compensation for a biosensor |